ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases. The company was formerly known as Ikena Oncology, Inc. and changed its name to ImageneBio, Inc. in July 2025. ImageneBio, Inc. is headquartered in San Diego, California. Show more
Location: 12526 High Bluff Drive, San Diego, CA, 92130, United States | Website: https://www.inmagenebio.com | Industry: Biotechnology | Sector: Healthcare
Market Cap
75.7M
52 Wk Range
$5.70 - $19.20
Previous Close
$6.77
Open
$6.80
Volume
4,845
Day Range
$6.71 - $7.02
Enterprise Value
-63.44M
Cash
142.6M
Avg Qtr Burn
-11.03M
Insider Ownership
15.04%
Institutional Own.
50.67%
Qtr Updated
09/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
